Company Takeda Pharmaceutical Company Limited

Equities

4502

JP3463000004

Pharmaceuticals

Market Closed - Japan Exchange 02:00:00 2024-05-21 EDT 5-day change 1st Jan Change
4,133 JPY -0.77% Intraday chart for Takeda Pharmaceutical Company Limited +0.76% +1.95%

Business Summary

Takeda Pharmaceutical Company Limited specializes in the development, manufacturing and marketing of pharmaceutical products especially for metabolic and cardiovascular diseases, cancers and central nervous systems troubles. The activity is organized around 2 areas:

- sale of drugs and consumer care products;

- services.

Net sales are distributed geographically as follows: Japan (17.5%), Asia (5%), the United States (49%), Europe and Canada (20.8%), Latin America (3.8%), Russia and CIS (1.8%) and other (2.1%).

Number of employees: 49,095

Sales per Business

JPY in Million2022Weight2023Weight Delta
Gastrointestinal
27.2 %
875,685 24.5 % 1,094,541 27.2 % +24.99%
Plasma Derivatives (Immune)
16.8 %
506,951 14.2 % 678,443 16.8 % +33.83%
Neuroscience
15.8 %
482,294 13.5 % 637,711 15.8 % +32.22%
Other
11.3 %
624,150 17.5 % 454,598 11.3 % -27.17%
Oncology
10.9 %
468,730 13.1 % 438,742 10.9 % -6.40%
Rare Genetic Disease and Others
10.4 %
- - 418,724 10.4 % -
Rare Hematology
7.6 %
283,689 7.9 % 304,718 7.6 % +7.41%

Sales per region

JPY in Million2022Weight2023Weight Delta
United States
52.2 %
1,714,421 48.0 % 2,103,772 52.2 % +22.71%
Europe and Canada
20.9 %
739,168 20.7 % 842,668 20.9 % +14.00%
Japan
12.7 %
658,983 18.5 % 512,043 12.7 % -22.30%
Asia
5.6 %
196,964 5.5 % 225,007 5.6 % +14.24%
Latin America
4.0 %
128,467 3.6 % 160,375 4.0 % +24.84%
Other
2.4 %
68,945 1.9 % 95,182 2.4 % +38.05%
Russia / Commonwealth of Independent States
2.2 %
62,057 1.7 % 88,431 2.2 % +42.50%

Managers

Managers TitleAgeSince
Chief Executive Officer 57 14-03-31
Chief Tech/Sci/R&D Officer 45 22-01-31
Compliance Officer 54 11-12-31
Chief Tech/Sci/R&D Officer 69 15-03-31
Chief Tech/Sci/R&D Officer 58 15-01-31
Compliance Officer - -
Director/Board Member 53 14-12-31
Public Communications Contact - -
Public Communications Contact - -
Investor Relations Contact - 11-05-31

Members of the board

Members of the board TitleAgeSince
Director/Board Member 71 16-05-31
Director/Board Member 62 18-12-31
Director/Board Member 71 18-12-31
Director/Board Member 60 22-05-31
Director/Board Member 64 16-05-31
Chairman 73 21-05-31
Director/Board Member 72 16-05-31
Chief Executive Officer 57 14-03-31
Director/Board Member 53 14-12-31
Director/Board Member 53 22-05-31

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 0 1,582,418,725 1,568,419,964 ( 99.12 %) 13,405,261 ( 0.8471 %) 99.12 %

Shareholders

NameEquities%Valuation
BlackRock Fund Advisors
3.496 %
55,319,129 3.496 % 1 460 M ¥
BlackRock Japan Co. Ltd.
2.276 %
36,020,800 2.276 % 951 M ¥
Nikko Asset Management Co., Ltd.
2.194 %
34,711,100 2.194 % 916 M ¥
Nippon Life Insurance Co.
1.564 %
24,752,000 1.564 % 653 M ¥
Takeda Science Foundation
1.132 %
17,912,000 1.132 % 473 M ¥
7,511,300 0.4747 % 198 M ¥
BlackRock Investment Management (UK) Ltd.
0.3774 %
5,972,275 0.3774 % 158 M ¥
BlackRock (Netherlands) BV
0.2850 %
4,509,380 0.2850 % 119 M ¥
Takeda Pharmaceutical Employee Incentive Plan
0.2294 %
3,630,339 0.2294 % 96 M ¥
Sumitomo Mitsui Trust Asset Management Co., Ltd.
0.1929 %
3,052,899 0.1929 % 81 M ¥
NameEquities%Valuation
Nikko Asset Management Co., Ltd.
2.762 %
87,400,834 2.762 % 1 142 M ¥
Capital Research & Management Co. (Global Investors)
0.4146 %
13,121,930 0.4146 % 172 M ¥
Mondrian Investment Partners Ltd.
0.3817 %
12,079,962 0.3817 % 158 M ¥
Eaton Vance Management
0.1578 %
4,995,623 0.1578 % 65 M ¥
The Ayco Co. LP
0.1330 %
4,209,431 0.1330 % 55 M ¥
Renaissance Technologies LLC
0.0985 %
3,118,200 0.0985 % 41 M ¥
Brandes Investment Partners LP
0.0917 %
2,902,507 0.0917 % 38 M ¥
Fidelity Management & Research Co. LLC
0.0813 %
2,574,240 0.0813 % 34 M ¥
Wells Fargo Bank NA
0.0813 %
2,571,467 0.0813 % 34 M ¥
Millennium Management LLC
0.0734 %
2,322,444 0.0734 % 30 M ¥
NameEquities%Valuation
BB Gestão de Recursos DTVM SA
0.000100 %
1,576 0.000100 % 20 546 ¥

Holdings

NameEquities%Valuation
7,511,300 0.47% 198,229,742 $
6,724,000 13.53% 80,822,480 $
4,214,559 2.96% 63,049,803 $
2,204,000 7.21% 32,619,178 $
8,781,996 12.42% 26,258,168 $
2,790,480 4.77% 25,393,368 $
8,119,800 18.76% 8,358,928 $
1,096,892 0.90% 5,199,268 $

Company contact information

Takeda Pharmaceutical Co., Ltd.

4-1-1 Dosho-machi Chuo-Ku

540-8645, Osaka

+81 3 3278 2111

http://www.takeda.co.jp
address Takeda Pharmaceutical Company Limited(4502)

Group companies

NameCategory and Sector
Shire Biotech India Pvt Ltd.
Medical Distributors
Pharmaceuticals: Major
Shire Ireland Finance Trading Ltd.
Financial Conglomerates
Financial Conglomerates
Pharmaceuticals: Major
Pharmaceuticals: Major
Pharmaceuticals: Major

Sales per Business

Sales per region

Trading Rating
Investor Rating
ESG Refinitiv
B+
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
18
Last Close Price
4,133 JPY
Average target price
4,762 JPY
Spread / Average Target
+15.23%
Consensus
  1. Stock Market
  2. Equities
  3. 4502 Stock
  4. Company Takeda Pharmaceutical Company Limited
-40% Exceptional extension: Our subscriptions help you unlock the best investment opportunities.
BENEFIT NOW